Connect with us:   Email This Page  | Print
The information on this site is designed for patients. If you are a healthcare professional, click here.
Learn more about Neuronetics, developer of the NeuroStar TMS Therapy System.
NeuroStar TMS Therapy® is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode. Click here for full prescribing and safety information
Find a Provider

Press Coverage

5/15/2008

ABC 7 Chicago News - Magnetic Minds

11/26/2007

ScienceDaily - Non-drug Treatment Effective For Major Depression, Study Suggests

11/19/2007

Transcranial Magnetic Stimulation (TMS): An Effective Treatment for Depression

5/22/2007

Medical News Today - NeuroStar® TMS Therapy Improved Quality Of Life In Patients With Major Depression In Clinical Trials

8/1/2006

Repetitive TMS: Depression Indication Sought

5/5/2006

WCBS-TV New York, Video Library - Experimental Treatment To Combat Depression

7/27/2004

The Bakersfield Channel - Study Tests Non-Invasive Depression Treatment

Press Releases

6/15/2008

NeuroStar® TMS Therapy Produced Significant Improvements in Depression Symptoms in Recently-Published Randomized, Controlled Trial

5/5/2008

New Data Analysis Identifies Depressed Patients Who are Most Likely to Benefit From Treatment with NeuroStar TMS Therapy

2/29/2008

NeuroStar® TMS Therapy Demonstrated Safety and Tolerability in Depression Clinical Trials According to Recent Peer-Reviewed Publication

5/21/2007

NeuroStar® TMS Therapy Improved Quality of Life in Patients with Major Depression in Clinical Trials

1/26/2007

FDA Advisory Panel Provides Positive Review On Safety Of NeuroStar® TMS Therapy For Patients With Depression

4/10/2006

Neuronetics Prepares for Product Launch

5/21/2005

New Treatment Options Emerging for Major Depression

5/2/2005

New Investigational Procedure to Treat Major Depression Being Tested in Global University Medical and Clinical Research Centers, May 2, 2005


Copyright © 2012 Neuronetics. All Rights Reserved Sitemap  | Privacy Policy  | Terms and Conditions  | Glossary

This link provides you with access to recent published information and news about NeuroStar TMS Therapy and new options for the treatment of depression. Neuronetics does not provide any assurances of the accuracy of this information and may not agree with the opinions of the authors.

NeuroStar TMS Therapy is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode. To return to the Neuronetics website for full safety and prescribing information click here.

Click here to continue.